Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers
Nico Gagelmann(Universität Hamburg), Nicolaus Kröger(Universität Hamburg), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Maija Itälä‐Remes(Turku University Hospital), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Jörg Halter(University Hospital of Basel), Carlos Solano(Hospital Clínico Universitario de Valencia), Francesca Bonifazi(University of Bologna), Ellen Meijer(Hospital General Universitario Gregorio Marañón), Andrea Bacigalupo(Università Cattolica del Sacro Cuore), Dieter Hoelzer(Endokrinologikum), Markéta Marková(Institute of Haematology and Blood Transfusion)
Cited by 112
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616